Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT

D. Currow (Sydney, Australia), S. Louw (Sydney, Australia), P. Mccloud (Sydney, Australia), B. Fazekas (Sydney, Australia), J. Plummer (Adelaide, Australia), C. Mcdonald (Adelaide, Australia), M. Agar (Sydney, Australia), K. Clark (Sydney, Australia), N. Mccaffrey (Melbourne, Australia), A. Abernethy (North Carolina, United States of America), M. Ekstrom (Lund, Sweden)

Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Session: Best abstracts in pulmonary rehabilitation and chronic care
Session type: Oral Presentation
Number: 1624
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Currow (Sydney, Australia), S. Louw (Sydney, Australia), P. Mccloud (Sydney, Australia), B. Fazekas (Sydney, Australia), J. Plummer (Adelaide, Australia), C. Mcdonald (Adelaide, Australia), M. Agar (Sydney, Australia), K. Clark (Sydney, Australia), N. Mccaffrey (Melbourne, Australia), A. Abernethy (North Carolina, United States of America), M. Ekstrom (Lund, Sweden). Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT. 1624

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A randomized double-blind placebo-controlled trial on the short and long-term effects of electro acupuncture on moderate to severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006

Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Efficacy of a short course of oral prednisolone for acute preschool viral-wheeze: a double-blind randomised placebo-controlled trial with stratification for systemic eosinophil priming
Source: Eur Respir J 2003; 22: Suppl. 45, 388s
Year: 2003

Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021
Year: 2021



The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Chinese herbs in treatment of postinfectious cough: A multi-centre, randomized, double-blind, placebo-controlled trial
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Gefapixant in two randomised dose-escalation studies in chronic cough
Source: Eur Respir J, 55 (3) 1901615; 10.1183/13993003.01615-2019
Year: 2020



Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018




Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
Source: Eur Respir J, 53 (1) 1801270; 10.1183/13993003.01270-2018
Year: 2019



BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021
Year: 2021



RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Omalizumab efficacy following cat allergen exposure: Results from a randomized, double-blind, placebo-controlled, parallel-group study in patients with moderate asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


A randomized, double-blind, placebo-controlled study to evaluate the role of formoterol in management of acute asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 498s
Year: 2006

A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study
Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021
Year: 2021



Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study
Source: Eur Respir J, 58 (1) 2001798; 10.1183/13993003.01798-2020
Year: 2021



Impact of oral clonidine on duration of opioid and benzodiazepine use in mechanically ventilated children: a randomized, double-blind, placebo-controlled study
Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Year: 2020